Atlas Trials

Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

Clinical trial NCT06408051 · COMPLETED

Trial details

NCT number
NCT06408051
Sponsor
Hisar Intercontinental Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment
Start date
2020-01-01
Primary completion
2022-01-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.